A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...
Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback